awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38612706-F1593289-1246-4A70-A982-817BC3312BA5
Q38612706-F1593289-1246-4A70-A982-817BC3312BA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612706-F1593289-1246-4A70-A982-817BC3312BA5
Immune checkpoint inhibitors: a new frontier in bladder cancer.
P2860
Q38612706-F1593289-1246-4A70-A982-817BC3312BA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612706-F1593289-1246-4A70-A982-817BC3312BA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51896a0b8b2a40fa8bba316d0447b703d4f70002
P2860
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.